ORINF (Orion Oyj) FFO


ORINF Orion Oyj ORINF
100 GF Score
Price $82.75
GF Value $86.78
! 2 Warning Signs
View Full Analysis

What is Orion Oyj FFO?

FFO (Funds from operations) only applies to REITs.

ORINF
100GF Score
Orion Oyj ORINF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Orion Oyj (ORINF) Overvalued in 2026?

Based on GuruFocus' analysis, Orion Oyj stock appears to be undervalued. The current stock price of $82.75 is trading 4.6% below its estimated GF Value™ of $86.78.

Key valuation signals for ORINF:

  • FFO:
  • GF Value™: $86.78 vs. price of $82.75 (4.6% below fair value)
  • GF Score™: 100/100 with 2 warning signs

No single metric tells the full story. See the ORINF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Orion Oyj Business Description

Address Orionintie 1, Espoo, FIN, FI-02200
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. The company mainly serves Finland but also has a presence in other European countries, North America and other countries.
100GF Score

Get the complete analysis for ORINF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$82.75
Price
$86.78
GF Value